NEWS

Knøttsmå biter av plast kan gi Parkinsons, ifølge studie på celler og mus – Gjenspeiler ikke mennesker, sier forsker

Likevel synes professor Charalampos Tzoulis det er en interessant teori.

DEC 6, 2023

lære mer

Anti-aldringsforsker: – Jeg spiser én om morgenen og én om kvelden

Anti-aldringsforskerne: En olje, en frukt og et vitamin inngår i dietten. – Kan forsinke alderen. Prof. Tzoulis kommentarer om emnet. 

SEP 22, 2023

Sandefjords Bladoa.noGlåmdalen PlussRanaBladTidens Krav Pluss

Liv Pilbeam (37) har Parkinson

Jeg vil at de skal huske meg.

AUG 13, 2023

lære mer

Our NADPARK study among the top-10 most influential studies published in Cell Metabolism in 2022!

In the “Best of Cell Metabolism 2022” collection, one of our studies entitled “The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease”, was highlighted as one of the 10 most exciting studies in metabolism research!

JUL 9, 2023

read morestudy publication

Sykehuset snur: Solfrid (77) får likevel fortsette på nødvendig medisin

Da det viste seg at Solfrid Lexau ikke hadde Parkinsons sykdom, fikk hun ikke lenger medisinen som virket på blå resept. Nå har sykehuset skiftet mening

MAY 26, 2023

lære mer

The importance of clinical studies

In an interview for the Norwegian Parkinson’s association, Prof. Tzoulis stresses the importance of clinical studies. The video features Ragnhild S. Støkket (Senior Advisor in Norges Parkinsonforbund), Charalampos “Haris” Tzoulis (Professor at Haukeland University Hospital and Neuro-SysMed Co-Director), Liv Pillbeam and Børge Pettersen, who both have Parkinson’s disease. 

MAY 20, 2023

intervju

Kan Parkinson skyldes denne bakterien?

Prof. Tzoulis var intervju for å kommentere emnet

MAY 16 and 21, 2023

forskning.no abc/nyheter

Prof. Tzoulis interviewed by Fox News on Parkinson’s disease and the prognostic value of age at onset

Richard Lewis diagnosed with late-onset Parkinson’s disease: ‘Luckily, I got it late in life’. Late-onset vs. early-onset Parkinson’s disease — here’s what to know.

APR 26, 2023

read more

Our Parkinson’s trial in the spotlight!

Our Parkinson’s trial in the spotlight! Thank you, Dr Ana Kriebs, for the elegant highlight in Nature Aging.

APR 7, 2022

read more

Prof. Tzoulis on national television (NRK) about challenges with diagnosing Parkinson’s disease

Prof. Tzoulis on national television (NRK) about challenges with diagnosing Parkinson’s disease: “Parkinsons er en vanskelig sykdom å diagnostisere. Spesielt i de tidlige fasene av sykdommen”.

MAR 30, 2023

lære mer

Forskningssenter for Parkinsons sykdom etableres i Bergen

Et nytt K.G. Jebsen-senter ved Universitetet i Bergen skal forske på årsaker til og behandling av Parkinsons sykdom.

MAR 10, 2022

lære merlære mer

Nytt senter for Parkinsons sykdom

Nytt senter for Parkinsons sykdom Et nytt senter ved Universitetet i Bergen skal forske på årsaker til, og behandling av Parkinsons sykdom. Senteret skal ledes av professor Charalampos Tzoulis.

MAR 10, 2022

Our newest study published in npj assesses the incidence, prevalence and mortality of Parkinson’s disease (PD)

Our newest study published in npj assesses the incidence, prevalence and mortality of Parkinson’s disease (PD) in the entire Norwegian population – we find that the epidemiology of PD is highly dynamic, and changes as a function of both age and time period.

MAR 2, 2022

study publication

Targeting the brain’s energy metabolism may hold the key for treating Parkinson’s disease

Promising results regarding potential treatment published in Cell Metabolism

MAR 2, 2022

read more

Tror på medisinsk gjennombrudd

Forsker og professor Charalampos Haris Tzoulis ved Haukeland universitetssjukehus tror forskningsgruppen hans står foran et gjennombrudd i parkinsonforskningen.

MAR 2, 2022

lære mer

Encouraging results from our phase-I trial (NADPARK)

Encouraging results from our phase-I trial (NADPARK)! Oral nicotinamide riboside holds promise as a neuroprotective therapy for Parkinson’s disease.

MAR 2, 2022

study publication

Our NAD-replenishment trials on national news!

Prof. Tzoulis on national television (NRK) about our NAD-replenishement trial! 

MAR 1, 2022

intervju

NRK news TV about NADPARK study results

NRK news TV about NADPark study results: Forskere i Bergen har håp om at de kan bremse sykdom som Parkinson’s med pille.

MAR 1, 2022

watch interview

Forska på Roar sin hjerne og gjorde enormt gjennombrot – gjev nytt håp til Parkinson

Forskarar i Bergen har som dei første i verda klart å auke mengda av eit viktig stoff i menneskehjernen.

MAR 1, 2022

read more

Major funding for our Parkinson’s research from the Norwegian Health Authorities

The Parkinson’s research program led by Prof. Charalampos Tzoulis at the Neuro-SysMed Center has been strengthened by grants from the regional and national Norwegian Health Authorities, amounting to more than 3 million Euros.

NOV 30, 2021

read more

Neurodegenerative diseases remain an unsolved mystery

Professor Charalampos Tzoulis stresses that neurodegenerative diseases, such as Parkinson’s disease, Alzheimer’s disease, and ALS, represent a global health emergency that can only be tackled through extensive research.

AUG 5, 2021

read more

In the lab: UiB – Charalampos “Haris” Tzoulis

I denne episoden drar vi på besøk til hjerneforsker Charalampos “Haris” Tzoulis ved UiB som viser frem hvordan de jobber med nedfryste hjerner.

SEP 18, 2020

watch video

Åpningen av Neuro-SysMed er viktig for hele hjerne-Norge

I dag åpnes forskningssenteret Neuro-SysMed ved Nevrologisk avdeling ved Haukeland universitetssjukehus og Universitetet i Bergen. Dette er Norges første forskningssenter for klinisk behandling, etablert som følge av en tildeling fra Forskningsrådet. Neuro-SysMed skal drive nasjonale kliniske studier ved ALS, Parkinsons sykdom, multippel sklerose og demens – svært alvorlige hjernesykdommer som i dag ikke kan kurere.

OCT 17, 2019

lære merlære mer

Congratulations to Dr Tran for the Novartis Research Prize!

Our PhD fellow Gia Tuong Thi Tran was awarded the Novartis Research Prize in Neurology and a grant of 125,000 NOK. Congratulations!

MAR 22, 2019

read more

Future of Health in Norway : Interview of Prof. Charalampos Tzoulis

Prof. Charalampos Tzoulis (Head of Neuromics group) has been interviewed for NRK1 about the future of Health in Norway.

DEC 12, 2018

watch interview

Kristoffer Haugarvoll awarded the prestigious Career Grant

Kristoffer Haugarvoll awarded the prestigious Career Grant of the Western Norway Health Authority. The grant amounts to approximately 1 million Euros and will support strategic research aiming to discover novel mechanisms and develop therapies for Alzheimer’s disease.

NOV 29, 2018

The Head of Neuromics, Charalampos Tzoulis, to lead Norway’s first Center of Excellence for Clinical Research in Brain Disease

Our group leader Prof. Charalampos Tzoulis and Prof. Kjell-Morten will lead the National center for brain disease. The center has been awarded to Haukeland University (Bergen, Hordaland) and University of Bergen by The Research Council of Norway (RCN). The center will perform groundbreaking research aiming to improve treatment for diseases affecting the nervous system, such as MS, ALS, Parkinson and dementia.

OCT 28, 2018